New drug cocktail aims to stop cervical cancer recurrence
Disease control
Not yet recruiting
This study tests whether combining two drugs, camrelizumab and famitinib, can help prevent cervical cancer from coming back after surgery. About 30 women with certain types of cervical cancer will receive this treatment for up to two years. The goal is to see if more women remain…
Phase: NA • Sponsor: Jin LI • Aim: Disease control
Last updated May 07, 2026 18:38 UTC